Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
Bear, Harry D, Prof, Tang, Gong, PhD, Rastogi, Priya, MD, Geyer, Charles E, Prof, Liu, Qing, PhD, Robidoux, André, Prof, Baez-Diaz, Luis, MD, Brufsky, Adam M, Prof, Mehta, Rita S, Prof, Fehrenbacher, Louis, MD, Young, James A, MD, Senecal, Francis M, MD, Gaur, Rakesh, MD, Margolese, Richard G, MD, Adams, Paul T, MD, Gross, Howard M, MD, Costantino, Joseph P, Prof, Paik, Soonmyung, Prof, Swain, Sandra M, Prof, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof
Published in The lancet oncology (01.09.2015)
Published in The lancet oncology (01.09.2015)
Get full text
Journal Article